Report: How Employers Can Better Manage GLP-1s for Adolescents
A new Nomi Health report found that GLP-1 use and spending among adolescents rose sharply from 2022 to 2025, raising concerns about future costs for self-insured employers.
Lilly Employer Connect Adds Flexibility for Employers But Isn’t Revolutionary, Expert Says
Eli Lilly’s new Lilly Employer Connect platform offers employers more flexible access to obesity drugs like Zepbound, but experts say it represents only incremental progress.
The Power of Real World Data to Study Women’s Health at Scale
Veradigm examines key clinical trends, comorbidity profiles, and treatment trends across adolescence, reproductive years, and peri-/post-menopause. Download it today!
GoodRx Launches Employer Program to Help Subsidize High-Cost Brand Drugs
GoodRx launched GoodRx Employer Direct, a program that allows employers to subsidize manufacturer-sponsored prices for high-cost brand medications like GLP-1s without adding them to their health insurance benefits.
Walgreens Introduces Virtual Weight Management Offering
Walgreens launched a virtual weight management program offering clinician support and GLP-1 prescriptions for self-pay patients.
What if Oprah Knew About Fractyl Health?
People like Oprah Winfrey have struggled to maintain their weight loss after weaning themselves off GLP-1s. What if an outpatient medtech procedure did the trick?
Nvidia CEO to Lilly CEO: You were running around the forest …
Jensen Huang, CEO of Nvidia and David Ricks, CEO of Eli Lilly, discussed their recently-announced partnership and the potential of GLP-1s at an event in San Francisco.
presented by
Inside an Automated Healthcare Practice: Redesigning Care Around People, Not Paperwork
By reducing administrative burden and redesigning workflows around human needs, it creates space for what matters most: connection between clinicians and patients.
Berry Street Introduces GLP-1 Nutrition Program
Berry Street's new GLP-1 nutrition program supports patients who are starting GLP-1s, currently taking them or transitioning off of them. Patients receive care from registered dietitians and certified nutrition specialists.
GLP-1s Come With High Price Tags and Major Side Effects. Could Microdosing Be the Answer?
Noom recently launched a microdosing program for GLP-1s. However, some are concerned about the use of compounded GLP-1s in this program, as they are not FDA-approved.